Expression of blood group A antigen during erythroid differentiation in A1 and A2 subjects. 1987

M Tulliez, and J L Villeval, and F Lejeune, and A Henri, and U Testa, and M Titeux, and H Rochant, and J Breton-Gorius, and W Vainchenker
Inserm U. 91, Hôpital Henri Mondor, Creteil, France.

The expression of blood group A antigen on marrow and blood cells from A1 and A2 subjects was investigated by the binding of Helix pomatia and Dolichos biflorus lectins using immunofluorescence. These two lectins stained BFU-E-derived colonies from A subjects in the early days of culture before the expression of glycophorin. The erythroid origin of these cells was ascertained by the coexpression of two other very early erythroid markers. In bone marrow, the ultrastructural immunogold method revealed that the entire erythroid lineage including proerythroblasts was labeled by HPA, whereas no staining was observed on granulomonocytic cells including myeloblasts. Platelets from A subjects were HPA-labeled and so were platelets from an O subject preincubated in A plasma. Megakaryocytes obtained in CFU-MK-derived colonies were weakly and heterogeneously labeled by the HPA lectin. Cultures from A1 and A2 subjects were the reflection of the genetic differences only when investigations were performed on mature erythroblasts. In contrast, the great majority of immature erythroblasts both from A2 and A1 subjects were equally labeled by both lectins; during further erythroid maturation, binding of both lectins markedly diminished only on A2 erythroblasts. When marrow erythroblasts were investigated at electron microscopic level, heterogeneity of labeling among all stages of maturation was clearly observed in A2 subjects, with staining stronger on immature than on mature erythroblasts. Therefore, the genetic differences between A1 and A2 subjects are revealed during terminal erythroid differentiation.

UI MeSH Term Description Entries
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004900 Erythroblasts Immature, nucleated ERYTHROCYTES occupying the stage of ERYTHROPOIESIS that follows formation of ERYTHROID PRECURSOR CELLS and precedes formation of RETICULOCYTES. The normal series is called normoblasts. Cells called MEGALOBLASTS are a pathologic series of erythroblasts. Erythrocytes, Nucleated,Normoblasts,Proerythroblasts,Pronormoblasts,Erythroblast,Erythrocyte, Nucleated,Normoblast,Nucleated Erythrocyte,Nucleated Erythrocytes,Proerythroblast,Pronormoblast
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D004920 Erythropoiesis The production of red blood cells (ERYTHROCYTES). In humans, erythrocytes are produced by the YOLK SAC in the first trimester; by the liver in the second trimester; by the BONE MARROW in the third trimester and after birth. In normal individuals, the erythrocyte count in the peripheral blood remains relatively constant implying a balance between the rate of erythrocyte production and rate of destruction. Erythropoieses
D006021 Glycophorins The major sialoglycoprotein of human erythrocyte membranes. It consists of at least two sialoglycopeptides and is composed of 60% carbohydrate including sialic acid and 40% protein. It is involved in a number of different biological activities including the binding of MN blood groups, influenza viruses, kidney bean phytohemagglutinin, and wheat germ agglutinin. Erythrocyte Sialoglycoproteins,Glycoconnectin,Glycoconnectins,Glycophorin,Glycophorin D,MN Sialoglycoprotein,Red Blood Cell Membrane Sialoglycoprotein,Glycophorin A,Glycophorin A(M),Glycophorin B,Glycophorin C,Glycophorin E,Glycophorin HA,Ss Erythrocyte Membrane Sialoglycoproteins,Ss Sialoglycoprotein,beta-Sialoglycoprotein,Sialoglycoprotein, MN,Sialoglycoprotein, Ss,Sialoglycoproteins, Erythrocyte,beta Sialoglycoprotein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000017 ABO Blood-Group System The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane. ABH Blood Group,ABO Blood Group,ABO Factors,Blood Group H Type 1 Antigen,H Blood Group,H Blood Group System,ABO Blood Group System,Blood Group, ABH,Blood Group, ABO,Blood Group, H,Blood-Group System, ABO,Factors, ABO,System, ABO Blood-Group
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

M Tulliez, and J L Villeval, and F Lejeune, and A Henri, and U Testa, and M Titeux, and H Rochant, and J Breton-Gorius, and W Vainchenker
January 1990, Glycoconjugate journal,
M Tulliez, and J L Villeval, and F Lejeune, and A Henri, and U Testa, and M Titeux, and H Rochant, and J Breton-Gorius, and W Vainchenker
August 2006, Transplantation,
M Tulliez, and J L Villeval, and F Lejeune, and A Henri, and U Testa, and M Titeux, and H Rochant, and J Breton-Gorius, and W Vainchenker
November 1999, British journal of haematology,
M Tulliez, and J L Villeval, and F Lejeune, and A Henri, and U Testa, and M Titeux, and H Rochant, and J Breton-Gorius, and W Vainchenker
March 1996, Molecular and cellular endocrinology,
M Tulliez, and J L Villeval, and F Lejeune, and A Henri, and U Testa, and M Titeux, and H Rochant, and J Breton-Gorius, and W Vainchenker
March 1996, Transfusion medicine (Oxford, England),
M Tulliez, and J L Villeval, and F Lejeune, and A Henri, and U Testa, and M Titeux, and H Rochant, and J Breton-Gorius, and W Vainchenker
January 1982, Advances in experimental medicine and biology,
M Tulliez, and J L Villeval, and F Lejeune, and A Henri, and U Testa, and M Titeux, and H Rochant, and J Breton-Gorius, and W Vainchenker
November 1989, American journal of clinical pathology,
M Tulliez, and J L Villeval, and F Lejeune, and A Henri, and U Testa, and M Titeux, and H Rochant, and J Breton-Gorius, and W Vainchenker
January 1988, Transfusion,
M Tulliez, and J L Villeval, and F Lejeune, and A Henri, and U Testa, and M Titeux, and H Rochant, and J Breton-Gorius, and W Vainchenker
January 1990, Zeitschrift fur Rechtsmedizin. Journal of legal medicine,
M Tulliez, and J L Villeval, and F Lejeune, and A Henri, and U Testa, and M Titeux, and H Rochant, and J Breton-Gorius, and W Vainchenker
November 1981, European journal of biochemistry,
Copied contents to your clipboard!